Pengusaha Australia secara terbuka memaparkan proses lengkap desain vaksin kanker mRNA untuk hewan peliharaan menggunakan AI, melibatkan data gen 300GB dan kolaborasi multi-model

Odaily星球日报讯 Australia AI consulting company founder Paul Conyngham posted on the X platform, revealing the complete technical process of designing a personalized mRNA cancer vaccine for a pet dog using multiple AI chatbots. The dog was diagnosed with malignant mast cell cancer in May 2024, and approximately 300GB of data was obtained through whole-genome and RNA sequencing. The target selection, protein structure modeling, and vaccine sequence design were completed with the collaboration of ChatGPT, Gemini, and Grok, ultimately identifying the c-KIT gene mutation and selecting 7 new antigen targets.

The vaccine was prepared by a related research team from the University of New South Wales and administered at the University of Queensland’s veterinary school. The overall treatment plan includes the combined use of mRNA vaccines, tyrosine kinase inhibitors, and PD-1 inhibitors, with the administration timing planned with AI assistance. After starting treatment in December 2025, some tumors shrank within three months, but there were still unresponsive lesions that required surgical intervention. Experts noted that this case represents an individual practice and does not constitute a universal medical conclusion.